Similar Papers

Paper Title
Journal
Date
Author
The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
G.W Lee ... J.Y Park
Gynecologic Oncology | VOL. 145
G.W Lee, et. al.G.W Lee ... J.Y Park
01 Jun 2017
Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study
Satoshi Tamauchi ... Fumitaka Kikkawa
American Journal of Obstetrics and Gynecology | VOL. 219
Satoshi Tamauchi, et. al.Satoshi Tamauchi ... Fumitaka Kikkawa
04 Aug 2018
Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report
Montassar Ghalleb ... Khaled Rahal
Journal of Medical Case Reports | VOL. 11
Montassar Ghalleb, et. al.Montassar Ghalleb ... Khaled Rahal
01 Dec 2017
Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study.
Ghada Hosny ... Sabah Ahmed Fadel
International Journal of Surgical Pathology | VOL. 32
Ghada Hosny, et. al.Ghada Hosny ... Sabah Ahmed Fadel
11 May 2023
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Editorial Board
-
European Journal of Cancer | VOL. 216
--
01 Feb 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Guilhem Roubaud ... Karim Fizazi
European Journal of Cancer | VOL. -
Guilhem Roubaud, et. al.Guilhem Roubaud ... Karim Fizazi
01 Feb 2025
Editorial Board
-
European Journal of Cancer | VOL. 217
--
01 Feb 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Karin P.S Langenberg ... Jan J Molenaar
European Journal of Cancer | VOL. -
Karin P.S Langenberg, et. al.Karin P.S Langenberg ... Jan J Molenaar
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.